New drugs not only offer hope, but possibly a better quality of life, for those awaiting new treatments. However, new drug approvals can also spark controversy. The FDA approved 17 new drugs this summer (June-August 2010). Many offer new promise, and one in particular promises a great deal of future debate.
Since nearly one in three Americans has high blood pressure, it isn't surprising that two of the 17 newly approved drugs are antihypertensives. The most recently approved drug is Tekamlo (aliskiren and amlodipine) from Novartis, a single-pill combination drug for high blood pressure. Tribenzor is a new three-in-one combination drug that is taken once-daily to treat high blood pressure.
The most controversial newly approved drug is the emergency contraceptive ella (ulipristal acetate) that can prevent pregancy for up to 5 days after sex. Plan B, the so-called morning after pill, is less effective and can only be used within 3 days of having sex. ella has been available as ellaOne in Europe since May 2009 and will be available to US women this fall.
Many are against the FDA approval of ella as a contraceptive when it can be used to induce abortion. Representative Chris Smith (R-NJ) says this classification may pave the way to “covertly allow federal funding for abortion." (1) Supporters and opponents agree this approval highlights the increasing influence of the FDA on political ideology and will be entangled with future political and regulatory battles.
A promising new drug, Cuvposa (glypopyrrolate), is the first liquid treatment for children who suffer from chronic severe drooling associated with neurologic conditions such as cerebral palsy. The FDA reports that 78% of children on this drug reached clinical improvement during trials.
The 17 new drugs approved this summer with their indications are listed in Figure 1. New drugs for asthma (Dulera), enlarged prostate (Jalyn), migraine (Alsuma), osteoporosis (Prolia), acne (Veltin), and erectile dysfunction (Staxyn) are a sampling of 2010 FDA approvals.
Figure 1: FDA Newly Approved Drugs Summer 2010 (June-August)
|
Drug |
Approval 2010 |
Company |
Indication |
|
Tekamlo (aliskiren and amlodipine) | August 26 |
||
|
ella (aliskiren and amiodipine) |
August 13 |
HRA Pharma | Postcoital Contraception - emergency contraception |
Suprep (sodium sulfate, potassium sulfate, magnesium sulfate) - Oral | August
5 |
Bowel Preparation – cleansing colon prior to colonoscopy |
|
|
Xeomin (incobotulinumtoxinA) | July 30 | ||
Cuvposa (glycopyrrolate) Oral Solution | July 28 | Chronic Drooling in Children |
|
|
Lastacaft (alcaftadine) Ophthalmic Solution |
July 28 |
|
Allergic Conjunctivitis - itchy eyes associated with eye allergies |
Tribenzor (amlodipine, hydrochlorothiazide and olmesartan) Tabs | July 23 |
Hypertension – once-daily treatment |
|
|
Veltin (clindamycin and tretinoin) Gel - formerly Velac |
July
16 |
Acne
- antibiotic and retinoid for topical treatment of acne |
|
|
Zuplenz (ondansetron) Oral
Soluble Film |
July
2 |
|
Prevention
of Chemotherapy-Induced, Radiotherapy-Induced, and Postoperative Nausea and Vomiting |
|
Glassia (alpha1-proteinase inhibitor Injection) - formerly AAT-IV | July
1 |
|
Alpha-1 Proteinase Inhibitor Deficiency – in adults with emphysema |
|
Butrans (buprenorphine) Transdermal System | June
30 |
Pain – management of moderate to severe chronic pain | |
Alsuma (sumatriptan) Injection | June 29 | ||
|
Dulera (mometasone furoate and formoterol fumarate) Inhaler | June
22 |
|
Asthma – in people 12 years of age and older |
Staxyn (vardenafil) Orally
Disintegrating Tablets |
June
17 |
GlaxoSmithKline and Merck & Co. |
|
|
Jevtana (cabazitaxel) Injection |
June
17 |
|
Prostate Cancer - in combination with prednisone for hormone-refractory metastatic
prostate cancer |
|
Jalyn (dutasteride and tamsulosin) Capsules |
June 14 |
|
Benign Prostatic Hyperplasia – in men with enlarged prostate |
Prolia (denosumab) Injection |
June
1 |
Osteoporosis – in women at high risk for fracture |
Popular Celebrity Cancer Searches for August 2010
10 Healthiest Foods
10 Trending Health Topics...Hot Off the Press
5 Trending Health Topics: Health Questions You're Too Afraid to Ask
10 Trending Health Searches: Crisis-Everywhere-You-Turn Edition (April 26-May 2)
5 Trending Health Topics: Healthy Skin Edition
By Julie Bohlen, MBA/HCM, ELS
http://www.blogcatalog.com/directory/lifestyle/health/

SEO services provided by Search Engine Optimization
Add blog to our blog directory.
The New York Times
Medical News Today
WebMD
PsychCentral
CNN
EverydayHealth
Healthline
Mayo Clinic
AOL Health
Yahoo! Health
National Cancer Institute
Sign up today to get OrganizedWisdom delivered to your inbox
Subscribe